Dare Bioscience Inc. logo

Dare Bioscience Inc.

DARE | NASDAQ
Chart Builder DCF Calculator
$0.87
+$0.06 (+7.41%)
Sep 22, 2026, 2:00 PM ET · Market open

Market Data

Market Cap
$12.13M
Enterprise Value
$533.95K
Beta
1.01
Average Volume
559.01K
Shares Outstanding (Diluted)
14.89M
Shares Change YoY
67.85%
Institutional Ownership
7.06%
Exchange
NASDAQ
ISIN
US23666P2002

Price Performance

Price Change 1M
-1.2%
Price Change 3M
-60.9%
Price Change 6M
-42.1%
Price Change YTD
-58.5%
Price Change 1Y
-60.3%
Price Change 3Y
-85.3%
Price Change 5Y
-96.1%
1M CAGR (ann.)
-42.1%
1Y CAGR (ann.)
-61.1%
5Y CAGR (ann.)
-47.4%
All-Time CAGR
-42.6%

Valuation

PE Ratio
-1.03
Forward PE
0.17
PEG Ratio
-0.01
Forward PEG
0.02
PS Ratio
8.88
Forward PS
1.40
PB Ratio
-21.66
P/FCF Ratio
-1.03
P/Adj. FCF Ratio
-0.92
P/OCF Ratio
-1.07
EV/Sales
0.39
EV/EBIT
-0.05
EV/EBITDA
-0.06
EV/FCF
-0.05
Earnings Yield
-97.5%
FCF Yield
-96.9%
Adj. FCF Yield
-109.3%

Financial Health

Net Cash
$11.6M
Total Debt
$1.02M
Cash & Short-Term Investments
$12.62M
Total Assets
$22.37M
Current Ratio
0.99
Quick Ratio
0.99
Debt / Equity Ratio
-12.08
Debt / EBITDA
-0.11
Debt / FCF
-0.09
OCF / Debt
-11.10
Interest Coverage
-55.72
Altman Z-Score
-13.40
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
-89.5%
Operating Profit Margin
-813.4%
EBITDA Margin
-672.6%
Net Profit Margin
-804.4%
FCF Margin
-860.6%
Adj. FCF Margin
-970.6%
SBC / Revenue
110.0%
SBC Impact (per share)
-12.8%

Returns

Return on Assets
-49.1%
Return on Equity
-748.1%
Return on Invested Capital
-179.1%
Return on Capital Employed
-203.9%
Return on Tangible Assets
-49.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
-52.8%
Revenue CAGR 5Y
-60.9%
Revenue CAGR 10Y
10.5%
EPS CAGR 3Y
10.5%
EPS CAGR 5Y
32.1%
EPS CAGR 10Y
28.6%
FCF CAGR 3Y
-3.4%
FCF CAGR 5Y
25.9%
FCF CAGR 10Y
1.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
97.0%
Revenue Growth Next 3Y
325.9%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.14
EPS Growth Est (next Q)
-50.0%
Revenue Est (next Q)
$2.02M
Revenue Growth Est (next Q)
89127.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$1
Price Target Upside
23.5%

Cash Flow

Operating Cash Flow
$-11.29M
Free Cash Flow
$-11.76M
Adj. Free Cash Flow
$-13.26M
FCF Per Share
-$0.79
OCF Per Share
-$0.76
OCF/S Ratio
-826.8%

Income Statement

Revenue
$1.37M
Gross Profit
$-1.22M
Operating Income
$-11.11M
EBITDA
$-9.19M
Net Income
$-10.99M
EPS (Diluted)
-$0.79
Revenue / Employee
$59.39K
Profit / Employee
$-477.7K
Employees
23

© 2026 bestshares.com. All rights reserved.